Tag:
INC Research
Latest Headlines
Latest Headlines
UPDATED: GoBalto wants to save Big Pharma from bungling one big thing
Behind the huge and scary numbers that accompany the costs of drug development, there are various holes and dysfunctional practices in the process of bringing a new drug to market.
GoBalto inks deal with INC for trial software
Fresh off raising $12 million in Series B financing, goBalto has lured a major CRO with its cloud-based clinical development platform, signing a deal with INC Research.
INC expands clinical ops in South Korea
INC Research is boosting its presence in South Korea with a new clinical development facility, citing the country's recent progress in supporting the biopharmaceutical industry.
AstraZeneca welcomes Soriot as new CEO; O'Day and Diggelmann move up within Roche
Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad) from your shop to Alison Bryant ( email | Twitter ) and Nesa Nourmohammadi (...
UPDATED: INC picks three of its own for new C-level spots
The North Carolina CRO announced that Chief Operating Officer Jamie Macdonald will assume the role of CEO beginning next year, marking one of three C-level promotions within the company.
INC Research to close another facility, laying off around 30
INC is facing another facility closure. Its clinical study unit in Morgantown, WV will be shut down, according to a story by The State Journal .
INC Research and Astellas expand alliance
The American CRO and the Japanese pharma star entered a three-year, functional service provider (FSP) alliance that kicked off earlier this month.
INC Research axes staffers, closes Connecticut lab
INC Research will let go of 66 employees from its facility in Old Lyme, CT, which will close this summer.
CROs jump into 2012 with big contracting momentum
Over the past few years the clinical research organization side of the industry has been undergoing a steady shakeout of small players as the big CROs lined up long-term deals with drug developers....
INC snags Kendle's global CRO operations for $232M in cash
Determined to vault into the top tier of the global CRO business, INC Research has struck a deal to buy out Kendle ( $KNDL ) for $232 million in cash. The deal gives INC global Phase I-IV operations
